Copyright Reports & Markets. All rights reserved.

Global Neurological Disease Model Chip Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Neurological Disease Model Chip Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Neuron Chip
    • 1.3.3 Brain Chip
    • 1.3.4 Brain Organ Chip
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Neurological Disease Model Chip Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Pharmaceutical R&D
    • 1.4.3 Neuroscience Research
    • 1.4.4 Clinical Diagnosis
  • 1.5 Global Neurological Disease Model Chip Market Size & Forecast
    • 1.5.1 Global Neurological Disease Model Chip Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Neurological Disease Model Chip Sales Quantity (2021-2032)
    • 1.5.3 Global Neurological Disease Model Chip Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Emulate
    • 2.1.1 Emulate Details
    • 2.1.2 Emulate Major Business
    • 2.1.3 Emulate Neurological Disease Model Chip Product and Services
    • 2.1.4 Emulate Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Emulate Recent Developments/Updates
  • 2.2 CN Bio
    • 2.2.1 CN Bio Details
    • 2.2.2 CN Bio Major Business
    • 2.2.3 CN Bio Neurological Disease Model Chip Product and Services
    • 2.2.4 CN Bio Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 CN Bio Recent Developments/Updates
  • 2.3 TissUse
    • 2.3.1 TissUse Details
    • 2.3.2 TissUse Major Business
    • 2.3.3 TissUse Neurological Disease Model Chip Product and Services
    • 2.3.4 TissUse Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 TissUse Recent Developments/Updates
  • 2.4 AxoSim Technologies
    • 2.4.1 AxoSim Technologies Details
    • 2.4.2 AxoSim Technologies Major Business
    • 2.4.3 AxoSim Technologies Neurological Disease Model Chip Product and Services
    • 2.4.4 AxoSim Technologies Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 AxoSim Technologies Recent Developments/Updates
  • 2.5 Nortis
    • 2.5.1 Nortis Details
    • 2.5.2 Nortis Major Business
    • 2.5.3 Nortis Neurological Disease Model Chip Product and Services
    • 2.5.4 Nortis Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Nortis Recent Developments/Updates
  • 2.6 Mimetas
    • 2.6.1 Mimetas Details
    • 2.6.2 Mimetas Major Business
    • 2.6.3 Mimetas Neurological Disease Model Chip Product and Services
    • 2.6.4 Mimetas Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Mimetas Recent Developments/Updates
  • 2.7 SynVivo
    • 2.7.1 SynVivo Details
    • 2.7.2 SynVivo Major Business
    • 2.7.3 SynVivo Neurological Disease Model Chip Product and Services
    • 2.7.4 SynVivo Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 SynVivo Recent Developments/Updates
  • 2.8 Axion Biosystems
    • 2.8.1 Axion Biosystems Details
    • 2.8.2 Axion Biosystems Major Business
    • 2.8.3 Axion Biosystems Neurological Disease Model Chip Product and Services
    • 2.8.4 Axion Biosystems Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Axion Biosystems Recent Developments/Updates
  • 2.9 Tara Biosystems
    • 2.9.1 Tara Biosystems Details
    • 2.9.2 Tara Biosystems Major Business
    • 2.9.3 Tara Biosystems Neurological Disease Model Chip Product and Services
    • 2.9.4 Tara Biosystems Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Tara Biosystems Recent Developments/Updates
  • 2.10 InSphero
    • 2.10.1 InSphero Details
    • 2.10.2 InSphero Major Business
    • 2.10.3 InSphero Neurological Disease Model Chip Product and Services
    • 2.10.4 InSphero Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 InSphero Recent Developments/Updates
  • 2.11 Hesperos
    • 2.11.1 Hesperos Details
    • 2.11.2 Hesperos Major Business
    • 2.11.3 Hesperos Neurological Disease Model Chip Product and Services
    • 2.11.4 Hesperos Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hesperos Recent Developments/Updates
  • 2.12 Kugelmeiers
    • 2.12.1 Kugelmeiers Details
    • 2.12.2 Kugelmeiers Major Business
    • 2.12.3 Kugelmeiers Neurological Disease Model Chip Product and Services
    • 2.12.4 Kugelmeiers Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Kugelmeiers Recent Developments/Updates
  • 2.13 Ascendance Biotechnology
    • 2.13.1 Ascendance Biotechnology Details
    • 2.13.2 Ascendance Biotechnology Major Business
    • 2.13.3 Ascendance Biotechnology Neurological Disease Model Chip Product and Services
    • 2.13.4 Ascendance Biotechnology Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Ascendance Biotechnology Recent Developments/Updates
  • 2.14 BioIVT
    • 2.14.1 BioIVT Details
    • 2.14.2 BioIVT Major Business
    • 2.14.3 BioIVT Neurological Disease Model Chip Product and Services
    • 2.14.4 BioIVT Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 BioIVT Recent Developments/Updates
  • 2.15 BGI Genomics
    • 2.15.1 BGI Genomics Details
    • 2.15.2 BGI Genomics Major Business
    • 2.15.3 BGI Genomics Neurological Disease Model Chip Product and Services
    • 2.15.4 BGI Genomics Neurological Disease Model Chip Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 BGI Genomics Recent Developments/Updates

3 Competitive Environment: Neurological Disease Model Chip by Manufacturer

  • 3.1 Global Neurological Disease Model Chip Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Neurological Disease Model Chip Revenue by Manufacturer (2021-2026)
  • 3.3 Global Neurological Disease Model Chip Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Neurological Disease Model Chip by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Neurological Disease Model Chip Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Neurological Disease Model Chip Manufacturer Market Share in 2025
  • 3.5 Neurological Disease Model Chip Market: Overall Company Footprint Analysis
    • 3.5.1 Neurological Disease Model Chip Market: Region Footprint
    • 3.5.2 Neurological Disease Model Chip Market: Company Product Type Footprint
    • 3.5.3 Neurological Disease Model Chip Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Neurological Disease Model Chip Market Size by Region
    • 4.1.1 Global Neurological Disease Model Chip Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Neurological Disease Model Chip Consumption Value by Region (2021-2032)
    • 4.1.3 Global Neurological Disease Model Chip Average Price by Region (2021-2032)
  • 4.2 North America Neurological Disease Model Chip Consumption Value (2021-2032)
  • 4.3 Europe Neurological Disease Model Chip Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Neurological Disease Model Chip Consumption Value (2021-2032)
  • 4.5 South America Neurological Disease Model Chip Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Neurological Disease Model Chip Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Neurological Disease Model Chip Sales Quantity by Type (2021-2032)
  • 5.2 Global Neurological Disease Model Chip Consumption Value by Type (2021-2032)
  • 5.3 Global Neurological Disease Model Chip Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Neurological Disease Model Chip Sales Quantity by Application (2021-2032)
  • 6.2 Global Neurological Disease Model Chip Consumption Value by Application (2021-2032)
  • 6.3 Global Neurological Disease Model Chip Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Neurological Disease Model Chip Sales Quantity by Type (2021-2032)
  • 7.2 North America Neurological Disease Model Chip Sales Quantity by Application (2021-2032)
  • 7.3 North America Neurological Disease Model Chip Market Size by Country
    • 7.3.1 North America Neurological Disease Model Chip Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Neurological Disease Model Chip Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Neurological Disease Model Chip Sales Quantity by Type (2021-2032)
  • 8.2 Europe Neurological Disease Model Chip Sales Quantity by Application (2021-2032)
  • 8.3 Europe Neurological Disease Model Chip Market Size by Country
    • 8.3.1 Europe Neurological Disease Model Chip Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Neurological Disease Model Chip Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Neurological Disease Model Chip Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Neurological Disease Model Chip Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Neurological Disease Model Chip Market Size by Region
    • 9.3.1 Asia-Pacific Neurological Disease Model Chip Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Neurological Disease Model Chip Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Neurological Disease Model Chip Sales Quantity by Type (2021-2032)
  • 10.2 South America Neurological Disease Model Chip Sales Quantity by Application (2021-2032)
  • 10.3 South America Neurological Disease Model Chip Market Size by Country
    • 10.3.1 South America Neurological Disease Model Chip Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Neurological Disease Model Chip Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Neurological Disease Model Chip Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Neurological Disease Model Chip Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Neurological Disease Model Chip Market Size by Country
    • 11.3.1 Middle East & Africa Neurological Disease Model Chip Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Neurological Disease Model Chip Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Neurological Disease Model Chip Market Drivers
  • 12.2 Neurological Disease Model Chip Market Restraints
  • 12.3 Neurological Disease Model Chip Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Neurological Disease Model Chip and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Neurological Disease Model Chip
  • 13.3 Neurological Disease Model Chip Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Neurological Disease Model Chip Typical Distributors
  • 14.3 Neurological Disease Model Chip Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Neurological Disease Model Chip market size was valued at US$ 60.49 million in 2025 and is forecast to a readjusted size of US$ 102 million by 2032 with a CAGR of 7.9% during review period.
    The neurological disease model chip is a biological simulation technology specifically used to simulate the pathogenesis and drug treatment effects of specific neurological diseases. This technology is usually implemented on a microfluidic chip or a microbial chip, and artificially cultured nerve cells or tissues are planted on the chip through tissue engineering and biotechnology means. Nervous disease model chips can be used to study a variety of neurological diseases, such as Parkinson's disease, Alzheimer's disease, epilepsy, stroke, etc. By simulating disease-related physiological and pathological processes as well as the effects of drugs on diseases, researchers can better understand the pathogenesis of neurological diseases and evaluate the efficacy and safety of potential treatments and drugs.
    The neurological disease model chip market is a high-profile market segment in the biomedical field and has shown a rapid growth trend in recent years. With the deepening of neuroscience research and the continuous advancement of technology, more and more scientific research institutions and pharmaceutical companies have begun to pay attention to and invest in this field, promoting the expansion of the market scale. Neurological disease model chips are widely used in many fields such as neuroscience research, drug research and development, disease diagnosis and treatment. By simulating the structure and function of the nervous system, it can help researchers gain a deeper understanding of the pathogenesis of neurological diseases and find new treatments. In summary, the neurological disease model chip market has broad application prospects and huge market potential.
    This report is a detailed and comprehensive analysis for global Neurological Disease Model Chip market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Neurological Disease Model Chip market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Neurological Disease Model Chip market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Neurological Disease Model Chip market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Neurological Disease Model Chip market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Neurological Disease Model Chip
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Neurological Disease Model Chip market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, CN Bio, TissUse, AxoSim Technologies, Nortis, Mimetas, SynVivo, Axion Biosystems, Tara Biosystems, InSphero, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Neurological Disease Model Chip market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Neuron Chip
    Brain Chip
    Brain Organ Chip
    Market segment by Application
    Pharmaceutical R&D
    Neuroscience Research
    Clinical Diagnosis
    Major players covered
    Emulate
    CN Bio
    TissUse
    AxoSim Technologies
    Nortis
    Mimetas
    SynVivo
    Axion Biosystems
    Tara Biosystems
    InSphero
    Hesperos
    Kugelmeiers
    Ascendance Biotechnology
    BioIVT
    BGI Genomics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Neurological Disease Model Chip product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Neurological Disease Model Chip, with price, sales quantity, revenue, and global market share of Neurological Disease Model Chip from 2021 to 2026.
    Chapter 3, the Neurological Disease Model Chip competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Neurological Disease Model Chip breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Neurological Disease Model Chip market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Neurological Disease Model Chip.
    Chapter 14 and 15, to describe Neurological Disease Model Chip sales channel, distributors, customers, research findings and conclusion.

    Buy now